trial

Art Therapy in Acute Schizophrenia

NCTId NCT01622166
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 60 (estimated)
Sponsored by Charite University, Berlin, Germany
Primary completion 2013-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2011-08
Primary completion
2013-01
Eligibility
ALL · 18 Years · 64 Years

Interventions & indications

Drugs
psychodynamic art therapy

Sponsors

Charite University, Berlin, GermanyLead Sponsor
Prof. K. Dannecker, Kunsttherapie Berlin Kunsthochschule Berlin-WeißenseeCollaborator

Investigators

1
Christiane Montag, M.D.Principal Investigator

Sites

1 total
Berlin, Germany

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2013-01
Status
COMPLETED
relationships
The graph out of here
drug
psychodynamic art therapy
drug
lead_sponsor
Charite University, Berlin, Germany
company
collaborator
Prof. K. Dannecker, Kunsttherapie Berlin Kunsthochschule Berlin-Weißensee
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Christiane Montag, M.D.
person